000 | 01057 a2200301 4500 | ||
---|---|---|---|
005 | 20250516024056.0 | ||
264 | 0 | _c20110725 | |
008 | 201107s 0 0 eng d | ||
022 | _a1471-4973 | ||
024 | 7 |
_a10.1016/j.coph.2011.01.004 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCodony, Xabier | |
245 | 0 | 0 |
_a5-HT(6) receptor and cognition. _h[electronic resource] |
260 |
_bCurrent opinion in pharmacology _cFeb 2011 |
||
300 |
_a94-100 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aClinical Trials, Phase II as Topic |
650 | 0 | 4 |
_aCognition _xdrug effects |
650 | 0 | 4 |
_aCognition Disorders _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aReceptors, Serotonin _xphysiology |
650 | 0 | 4 |
_aSerotonin Antagonists _xpharmacology |
700 | 1 | _aVela, Jose Miguel | |
700 | 1 | _aRamÃrez, Maria Javier | |
773 | 0 |
_tCurrent opinion in pharmacology _gvol. 11 _gno. 1 _gp. 94-100 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.coph.2011.01.004 _zAvailable from publisher's website |
999 |
_c20606936 _d20606936 |